A Tiered Approach to Reduce Hospital Onset C. difficile Brian Koll, MD, FACP, FIDSA Medical Director and Chief Infection Prevention and Control, BIMC.

Slides:



Advertisements
Similar presentations
Every Cloud has a Silver Lining Ms Maire Bermingham Assistant Director of Corporate Support Services Dr Naomi Baldwin Senior Infection Prevention and Control.
Advertisements

Debra Berube MS RNC CIC Director of Infection Control & Prevention St Vincent Hospital Worcester MA.
East Texas Medical Center – Tyler Annual Physician Education MDRO -Multidrug-Resistant Organisms- Revised: April 2013.
Performance Improvement Leadership Develop Program
The call The happy years The awakening Work to do Michelle Bushey, RN, BS, BSN, CIC Director Infection Prevention and Patient Safety.
BEST PRACTICES: MRSA PRECAUTIONS Dr. Elizabeth Bryce.
Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC.
Antimicrobial Resistance in Hospitals: Lack of Effective Treatment for Gram Negative Bacilli and the Rise of Resistant Clostridium difficile Infections.
There are no financial disclosures by any members of this project.
Case discussion Michael Gardam University Health Network.
Controlling MRSA Michael Gardam Director, Infection Prevention and Control University Health Network, Toronto National MRSA Intervention Lead
Multi-Clean Clostridium Difficile INTRODUCTION At times, special sanitation procedures may be implemented when directed by Hospital Infection Control Personnel.
2013 CLOSTRIDIUM DIFFICILE EDUCATIONAL AND CONSENSUS CONFERENCE March 11-12, 2013.
Multidisciplinary Task Force Cdiff Project Infection Preventionist Administration Environmental Services Personnel Registered Nurses Physicians Pharmacy.
New CLOSTRIDIUM DIFFICILE CDI Prevention Bundles
Jay Hamm, RN, FACHE, COO/Acute Care Executive Steve Shelton, MD, Medical Director EM Eric Brown, MD, Physician Executive.
 To decrease the rate of central line associated blood stream infections  To increase knowledge on the purpose and effectiveness of chlorhexidine gluconate.
Getting to Zero Strategies to Reduce Central Line Associated Bloodstream Infections (CLABs) Brian S. Koll, MD, FACP Medical Director, Infection Prevention.
Innovative Use of Electronic Hand Hygiene Monitoring to Control a Clostridium difficile cluster on a Hematopoietic Stem Cell Transplant Unit Natasha Robinson.
Antibiotic overuse and misuse in long term care Shira Doron, MD Assistant Professor of Medicine Division of Geographic Medicine and Infectious Diseases.
Preventing Multidrug-Resistant Organisms (MDROs) What the Direct Caregiver Should Know Prepared by: Ann Bailey, RNC, BSN, CIC Joanne Dixon, RN, MN, CIC.
C. Difficile Prevention Collaborative: Learning and change in Massachusetts September 2012 Susanne Salem-Schatz, Sc.D. HealthCare Quality Initiatives
MRSA in Corrections Danae Bixler, MD, MPH
Physicians: Infection Prevention is in YOUR Hands
Getting Started or so you are the new Infection Preventionist – what now? Karen Hoover Russ Olmsted Ruth Anne Rye.
Infection Prevention & Control Neil Wigglesworth Nurse Consultant, Infection Control 23 rd June 2008.
Factors Leading to the Spread of Vancomycin-Resistant Enterococci in US Hospitals Factors Antimicrobial pressure Environmental contamination and survival.
Recommendation on prudent use of antimicrobial agents in human medicine – Slovenian experiences Intersectoral Coordination Mechanism Prof. Milan Čižman,
Shira Doron, MD Assistant Professor of Medicine
Antimicrobial Stewardship St. Mary’s Hospital Infection Control Committee.
Infection Control Clinical Pharmacy and Patient Safety
A Team Approach at MRMC Kimberly E. Knox, RN, MHA, CIC.
Lou Ann Bruno, MD Chief of Infectious Diseases and Medical Director Of Infection Prevention NHSN Benchmark Med-Surg ICU:
Effect of prolonging Clostridium difficile (CD) treatment on recurrence rate in patients receiving concomitant systemic antibiotic therapy 5-yr retrospective.
Payment and Delivery Reform Steve Arner Senior Vice President / Chief Operating Officer June 6, 2013.
Comprehensive Unit based Patient Safety Program Deepa Jose,RN,CCRN.
Getting Started or so you are the new Infection Preventionist – what now? Karen Hoover Russ Olmsted Ruth Anne Rye.
ELLIS MEDICINE CLABSI REDUCTION IN THE ICU Eve Bankert, MT Director of Infection Prevention Kathleen Aidala, RN CCRN ICU Nursing Quality & Education Specialist.
© The Johns Hopkins University and The Johns Hopkins Health System Corporation, 2011 Providing Feedback: Structural Assessment 2 Results & Exposure Receipt.
The Perils of PPIs How can they harm us? What should they be used for?
Improving Infection Prevention and Antibiotic Stewardship through Quality Improvement Collaboratives: Tales from Two Successful Facilities Featuring: Melanie.
Milford Regional Medical Center’s Goal Targeting Zero for Nosocomial Clostridium Difficile Infection Rates Kim Knox, RN, Infection Control Practitioner.
U.S. Strategies to Improve Human Antibiotic Use Lauri A. Hicks, D.O. Director, Office of Antibiotic Stewardship April 13, 2016 National Center for Emerging.
Development of a Community Stroke Rehabilitation Team “meeting the need” NHS Blackburn with Darwen Tracy Walker Team Leader.
Nursing Orientation. All staff AND visitors should follow the precautions listed on the sign All PPE (personal protective equipment) should be on prior.
HELICOBACTER PYLORI Millions of years old microorganism of mankind Causes a spectrum of diseases Obviously requires high priority Treatment strategies.
1 Infectious Diseases in the Nursing Home Setting: Challenges and Opportunities for Clinical Investigation 감염내과 R2 김대호 / Prof. 이미숙 Manisha Juthani-Mehta.
JAMA Internal Medicine May 2015 Volume 175, Number5 R1 조한샘 / Prof. 이창균.
The Illinois Clostridium difficile Prevention Collaborative.
The AHRQ Safety Program for Improving Antibiotic Use
Loria Pollack, MD, MPH Division of Healthcare Quality Promotion
Reducing the Risk of Clostridium difficile Infection:
Performance Improvement Model Implications for Practice
How to use it to reduce the risk of CDAD in your ward
Additional Precautions
AHRQ Safety Program for Improving Antibiotic Use
Clostridium difficle Isolation precautions
The AHRQ Safety Program for Improving Antibiotic Use
AHRQ Safety Program for Improving Antibiotic Use
Improvement of management and reduction in mortality following implementation of audit recommendations in Clostridium difficile diarrhoea at James Cook.
The AHRQ Safety Program for Improving Antibiotic Use
Antimicrobial Resistance in Hospitals: Lack of Effective Treatment for Gram Negative Bacilli and the Rise of Resistant Clostridium difficile Infections.
Jeffrey F. Barletta, PharmD, Shareen Y. El-Ibiary, PharmD, Lindsay E
Hospital Antibiotic Stewardship Programs
Hand Hygiene & Contact Precautions Compliance Improvement Story
Antibiotic Stewardship at MetroWest Medical Center
Readmissions in 30 Days Quarterly
B. Huttner, S. Harbarth, D. Nathwani 
Cardiff and Vale UHB Dr Graham Shortland
C.P. Kelly  Clinical Microbiology and Infection 
Presentation transcript:

A Tiered Approach to Reduce Hospital Onset C. difficile Brian Koll, MD, FACP, FIDSA Medical Director and Chief Infection Prevention and Control, BIMC Professor of Medicine, AECOM

HO Clostridium difficile (CDI) CMS 10th SOW Goal is 10% reduction 6

HO Clostridium difficile (CDI) New York State DOH 7

HO Clostridium difficile (CDI) 10 th SOW BIMC 8

Tiered Approach 1. Hand hygiene 2. Contact precautions 3. Sign placement 4. PPE readily available and used 5. Dedicated rectal thermometers 9

Tiered Approach 6. Patient placement 7. Commodes 8. Environmental cleaning protocols 9. Chlorhexidine bathing 10

Tiered Approach 10. Antibiotic stewardship 11. Pharmaceutical stewardship 11

Begins with Leadership Accountability Link infection prevention with organizational strategy and resources Link a culture of safety to outcomes Engage and facilitate teamwork Goal setting and measuring and assessing effectiveness 12

Begins with Those on the Front Line 13

Begins with Those on the Front Line Ownership 14

Begins with Those on the Front Line Ownership 15

Begins with Those on the Front Line Ownership - Nursing University of Nebraska 1. bathing three days per week followed by 2. daily bathing followed by 3. four-month washout period returning to standard soap-and-water bathing 16 Infect Control Hosp Epidemiol 2012;33:

Begins with Those on the Front Line Ownership - Nursing 30% reduction in HO CDI with three days per week protocol 59% reduction with daily bathing 17 Infect Control Hosp Epidemiol 2012;33:

CDI Survey Antimicrobial Resistance: Scope of the Problem and Key Contributors Disagree Neither Agree 1. Antibiotic resistance is a problem in this institution. 5%17% 78% 2. Patient rooms are cleaned according to hospital cleaning protocol once a C. difficile patient has been discharged. 4%15% 81% 3. Adherence to hand hygiene protocols is excellent at this institution. 26%20% 54% 4. Adherence to isolation and contact precautions is excellent at this institution. 34%16% 50% 5. This institution does NOT do enough to control the development of C. difficile. 44% 30%26% 6. This institution provides adequate staff education regarding C. difficile. 12%36% 52% 18

Antibiotic Stewardship Community acquired pneumonia moxifloxacin vs ceftriaxone-based therapy colonization and infection with multidrug-resistant organisms higher in moxifloxacin group restriction policies to diminish moxifloxacin use Goldstein RC, Lalite S, Mildvan D, Perlman DC, Jodlowski T, Ruhe J. IDSA Poster Presentation 205. Boston, October

Antibiotic Stewardship 20

Begins with Those on the Front Line Ownership - Physicians San Francisco General Jun 2005 – Dec 2010 historical cohort study development of CDI within 30 days of ceftriaxone therapy 3,730 patients 21 Clinical Infectious Diseases Sept 1, 2012 Volume 55 page 615

Begins with Those on the Front Line Ownership - Physicians Multivariate analysis doxycycline associated with protection against development of CDI 27% lower rate Hazard ratios ctx + doxy vs ctx + azith = 0.15 vs ctx + fluoroquinolone = 0.13 Stongest predictor of CDI length of stay 22 Clinical Infectious Diseases Sept 1, 2012 Volume 55 page 615

Antibiotic Stewardship Clinical Infectious Diseases Sept 1, 2012 Volume 55 page

Proton Pump Inhibitors elderly underlying medical conditions broad spectrum antibiotics PPI 28 observational studies strength of association ranged from 1.4 to 2.8x higher Indications erosive gastritis symptomatic GERD NSAID gastric ulcer risk reduction H. pylori eradication 24

Proton Pump Inhibitors 25

HO CDI 26

HO Clostridium difficile (CDI) 10 th SOW BIMC 27

Value Analysis On the CUSP Calculator ▶ CDI Cases ▶ Increased Length of Stay ▶ Mortality ▶ Median Excess Costs ▶ Savings Based on Percent Reduction –Range $329,640 - $849,756

Tiered Approach 1. Successful 2. Involvement at all levels of the organization 3. Sustainable results 4. Assure continued improvement 29

The Team 30